Key facts
- Lineus Medical’s last known valuation is $20.0M (Sep 2022).
- It has raised $22.3M; the latest was Later Stage VC ($500K) in Mar 2026.
- Notable investors include Startupbootcamp Holding, Nashville Entrepreneur Center, Cadron Capital Partners, KMF Investments, ARK Investment Management — 17 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Lineus Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Lineus Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lineus Medical
Developer of a break-away intravenous therapy (IV) device designed to work with a variety of medical tubing. The company focuses on increasing the patient's overall quality of care during IV therapy by using technology to create a separation in the tubing which is created when excessive tension is exerted across a peripheral IV set, enabling medical practitioners to prevent access lines from becoming dislodged which can lead to blood loss and infection.
- Sector
- Healthcare
- HQ
- Fayetteville, AR, United States
- Employees
- 10
- Website
- lineusmed.com/
- Ownership
- Privately Held (backing)
Lineus Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lineus Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lineus Medical in its N-PORT filings yet. We sweep new filings monthly.